Related Experiment Video
Updated: Dec 4, 2025

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
Clinical characteristics of COVID-19 with cardiac injury: a systematic review and meta-analysis
Linwen Zeng1, Shihui Wang1, Jianing Cai1
1Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Insights
Older age, male gender, and comorbidities increase the risk of cardiac injury in COVID-19 patients. These patients face higher complication rates and mortality, highlighting the need for early cardiac injury prevention in COVID-19 care.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Cardiac injury is a significant predictor of poor prognosis in patients with 2019 novel coronavirus disease (COVID-19).
- Limited research has comprehensively investigated the specific risk factors contributing to cardiac injury in COVID-19 patients.
Purpose of the Study:
- To systematically analyze the clinical characteristics of COVID-19 patients.
- To identify potential risk factors associated with cardiac injury in COVID-19 virus infection.
Main Methods:
- A systematic literature search was conducted across major databases including Pubmed, Embase, Europe PMC, and CNKI.
- Statistical analyses were performed using STATA 16.0 on data from 5726 confirmed cases across 17 studies.
Main Results:
- Patients with cardiac injury were older, predominantly male, and had higher rates of comorbidities, clinical complications, mechanical ventilation, ICU transfer, and mortality compared to those without.
- Elevated levels of C-reactive protein, procalcitonin, D-dimer, NT-proBNP, and creatinine were observed in patients with cardiac injury, alongside decreased lymphocyte and platelet counts.
- Notably, cardiac injury in COVID-19 did not correlate with increased chest distress, chest pain, palpitations, smoking, or arrhythmias.
Conclusions:
- Age, male gender, and comorbidities are identified as key risk factors for cardiac injury in COVID-19.
- Cardiac injury in COVID-19 patients is linked to severe complications, abnormal laboratory findings, and adverse outcomes.
- Unlike typical cardiac conditions, COVID-19-related cardiac injury does not significantly manifest with symptoms like chest pain or arrhythmias, underscoring the need for proactive prevention strategies.
Objectives:
Cardiac injury is associated with poor prognosis of 2019 novel coronavirus disease 2019 (COVID-19), but the risk factors for cardiac injury have not been fully studied. In this study, we carried out a systematic analysis of clinical characteristics in COVID-19 patients to determine potential risk factors for cardiac injury complicated COVID-19 virus infection.
Methods:
We systematically searched relevant literature published in Pubmed, Embase, Europe PMC, CNKI and other databases. All statistical analyses were performed using STATA 16.0.
Results:
We analysed 5726 confirmed cases from 17 studies. The results indicated that compared with non-cardiac-injured patients, patients with cardiac injury are older, with a greater proportion of male patients, with higher possibilities of existing comorbidities, with higher risks of clinical complications, need for mechanical ventilation, ICU transfer and mortality. Moreover, C-reactive protein, procalcitonin, D-dimer, NT-proBNP and blood creatinine in patients with cardiac injury are also higher while lymphocyte counts and platelet counts decreased. However, we fortuitously found that patients with cardiac injury did not present higher clinical specificity for chest distress (P = 0.304), chest pain (P = 0.334), palpitations (P = 0.793) and smoking (P = 0.234). Similarly, the risk of concomitant arrhythmia (P = 0.103) did not increase observably either.
Conclusion:
Age, male gender and comorbidities are risk factors for cardiac injury complicated COVID-19 infection. Such patients are susceptible to complications and usually have abnormal results of laboratory tests, leading to poor outcomes. Contrary to common cardiac diseases, cardiac injury complicated COVID-19 infection did not significantly induce chest distress, chest pain, palpitations or arrhythmias. Our study indicates that early prevention should be applied to COVID-19 patients with cardiac injury to reduce adverse outcomes.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy I: Introduction and Classification

